Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort
暂无分享,去创建一个
U. Müller-Ladner | C. Denton | D. Khanna | M. Vonk | O. Distler | J. Seibold | J. Pope | V. McLaughlin | E. Grünig | D. Bonderman | R. Dobrota | H. Chadha‐Boreham | M. Antić | M. Doelberg | D. Rosenberg | C. Mihai | J. Coghlan
[1] J. Barberà,et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. , 2015, The New England journal of medicine.
[2] R. Benza,et al. Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry , 2014, Chest.
[3] D. Furst,et al. Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry , 2014, Arthritis care & research.
[4] M. Humbert,et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. , 2013, Arthritis and rheumatism.
[5] H. Heinzl,et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study , 2013, Annals of the rheumatic diseases.
[6] M. Humbert,et al. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era , 2012, Annals of the rheumatic diseases.
[7] M. Humbert,et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. , 2011, Arthritis and rheumatism.
[8] A. Gabrielli,et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres , 2011, Annals of the rheumatic diseases.
[9] M. Gatzoulis,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[10] P. Corris,et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. , 2009, American journal of respiratory and critical care medicine.
[11] A. Silman,et al. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. , 1999, Arthritis and rheumatism.
[12] T. Medsger,et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. , 1986, Arthritis and rheumatism.
[13] J. Vachiéry,et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.